Insiders · HOOK

Mark Winderlich

Chief Development Officer at HOOKIPA Pharma Inc. (HOOK) since April 2024

Mark Winderlich has filed 2 insider reports with the SEC since April 2024, as chief Development Officer at HOOKIPA Pharma Inc. (HOOK). The latest filing, on April 17, 2024, reports grant or award at HOOKIPA Pharma Inc. (HOOK).

Filings
2
Companies
1
Bought on market
None
Sold on market
None

Companies where Mark Winderlich is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
HOOKIPA Pharma Inc. logo
HOOK
HOOKIPA Pharma Inc.
Chief Development Officersince April 2024Apr 17, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Mark Winderlich with

Other insiders at the same companies

Questions about Mark Winderlich

What is Mark Winderlich's role at HOOKIPA Pharma Inc.?
Mark Winderlich reports to the SEC as chief Development Officer at HOOKIPA Pharma Inc. (HOOK), according to the latest filing on April 17, 2024.
Has Mark Winderlich bought or sold stock recently?
No open-market purchases or sales by Mark Winderlich are on file. The filings report grant or award.
How do I get alerts when Mark Winderlich files?
Follow Mark Winderlich on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Winderlich (SEC CIK 0002019241). Totals count each trade once, skipping amendments whose original is on file, from Apr 11, 2024 on. View on SEC EDGAR · Get this as JSON